Free Trial
Geulah Livshits

Geulah Livshits Analyst Performance

Senior Research Analyst, Biotech at Chardan Capital

Geulah Livshits is a stock analyst at Chardan Capital focused in the medical sector, covering 30 publicly traded companies. Over the past year, Geulah Livshits has issued 84 stock ratings, including and buy recommendations. While full access to Geulah Livshits' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Geulah Livshits' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
207 Last 7 Years
Buy Recommendations
98.55% 204 Buy Ratings
Companies Covered
30 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy98.6%204 ratings
Hold1.4%3 ratings
Sell0.0%0 ratings

Out of 207 total stock ratings issued by Geulah Livshits at Chardan Capital, the majority (98.6%) have been Buy recommendations, followed by 1.4% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
96.7% of companies on NASDAQ
29 companies
OTCMKTS
3.3% of companies on OTCMKTS
1 company

Geulah Livshits, an analyst at Chardan Capital, currently covers 30 companies listed on NASDAQ and OTCMKTS, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
28 companies
93.3%
Manufacturing
1 company
3.3%
Retail/Wholesale
1 company
3.3%

Geulah Livshits of Chardan Capital specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Retail/Wholesale companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
21 companies
70.0%
MED - DRUGS
4 companies
13.3%
PHARMACEUTICAL PREPARATIONS
2 companies
6.7%
MED - GENERIC DRG
1 company
3.3%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
1 company
3.3%
CATALOG & MAIL - ORDER HOUSES
1 company
3.3%

About Geulah Livshits

Dr. Geulah Livshits is a Senior Research Analyst at Chardan covering biotech companies, with a focus on gene editing and oncology. Dr. Geulah Livshits joined Chardan in the spring of 2018, after a career as an academic scientist. Prior to joining Chardan, Dr. Livshits was a Postdoctoral Research Fellow in the laboratory of Dr. Scott Lowe at Memorial Sloan Kettering Cancer Center, where she developed CRISPR and RNAi approaches to study pancreatic cancer in vivo and in organoid models. Dr. Livshits conducted her thesis research in the laboratory of Dr. Elaine Fuchs at The Rockefeller University, where she studied mechanisms of skin development and regeneration. Her doctoral and postdoctoral work has been published in peer-reviewed academic journals including Nature, Nature Medicine, Nature Biotechnology, eLife, PNAS, and Human Gene Therapy. Dr. Livshits received her BS from Brandeis University, her PhD from The Rockefeller University, and was a Postdoctoral Research Fellow at Memorial Sloan Kettering Cancer Center.
Follow on LinkedIn

Geulah Livshits' Ratings History at Chardan Capital

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
5/11/2026Reiterated Rating$3.63$11.00Buy
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
5/11/2026Reiterated Rating$5.97$17.00Buy
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
5/7/2026Lower Price Target$3.55$14.00Buy
Climb Bio, Inc. stock logo
CLYM
Climb Bio
5/5/2026Initiated Coverage$9.69$22.00Buy
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
5/5/2026Boost Price Target$3.04$4.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
4/27/2026Boost Price Target$13.92$30.00Buy
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
4/10/2026Reiterated Rating$3.67$16.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
3/31/2026Boost Price Target$124.65$240.00Buy
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
3/30/2026Lower Price Target$0.79$11.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
3/27/2026Reiterated Rating$3.77$11.00Buy
Tomorrow's Stock of the Day (Ad)

Looking for better stock ideas? Sign-up to receive The Early Bird Stock of the Day. Each day, MarketBeat's team of expert research analysts identifies one compelling stock and provides both a bull case and a bear case for each company.tc pixel

Get The Early Bird's Stock of the Day (Free)
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
3/20/2026Reiterated Rating$7.12$15.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
3/19/2026Reiterated Rating$8.72$26.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
3/19/2026Reiterated Rating$4.56$12.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
3/16/2026Reiterated Rating$126.89$210.00Buy
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
3/12/2026Reiterated Rating$7.72$15.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
3/12/2026Reiterated Rating$0.86$8.00Buy
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
3/9/2026Reiterated Rating$2.31$3.50Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
2/27/2026Reiterated Rating$14.28$26.00Buy
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
2/25/2026Lower Price Target$3.78$16.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
2/24/2026Boost Price Target$119.55$210.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
2/18/2026Boost Price Target$287.84$323.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2/14/2026Boost Price Target$53.07$76.00Buy
Passage Bio, Inc. stock logo
PASG
Passage Bio
2/10/2026Initiated Coverage$8.90$21.00Buy
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
1/13/2026Reiterated Rating$8.12$17.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
1/6/2026Reiterated Rating$5.21$12.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
12/18/2025Reiterated Rating$9.21$26.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
12/15/2025Boost Price Target$88.98$174.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
12/12/2025Lower Price Target$1.36$8.00Buy
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
12/11/2025Reiterated Rating$9.73$17.00Buy
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
12/9/2025Boost Price Target$1.75$13.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
11/26/2025Lower Price Target$53.57$74.00Buy
Immatics N.V. stock logo
IMTX
Immatics
11/24/2025Reiterated Rating$10.70$25.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
11/13/2025Reiterated Rating$6.62$20.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
11/13/2025Reiterated Rating$81.54$110.00Buy
Passage Bio, Inc. stock logo
PASG
Passage Bio
11/12/2025Boost Price Target$7.70$21.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
11/11/2025Boost Price Target$10.17$26.00Buy
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
11/10/2025Lower Price Target$3.81$9.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
11/10/2025Reiterated Rating$1.46$9.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
11/7/2025Boost Price Target$77.17$110.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
11/7/2025Lower Price Target$9.52$26.00Buy
BlackRock, JPMorgan, and Goldman are all stock piling the same asset… are you? (Ad)

BlackRock, JPMorgan, Goldman Sachs, Fidelity, ARK Invest and Andreessen Horowitz are all buying the same asset. The reason is tied to a legal mandate - the Clarity Act now requires the entire $382 trillion financial system to move onto a new monetary infrastructure by April 2027. BlackRock CEO Larry Fink calls it 'the next major evolution in market infrastructure.' Every transaction on this new grid burns one specific scarce digital resource - and institutions are accumulating shares before prices move.tc pixel

Discover the asset BlackRock, JPMorgan and Goldman are buying now
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
11/6/2025Lower Price Target$2.31$17.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
11/5/2025Reiterated Rating$4.27$12.00Buy
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
11/5/2025Reiterated Rating$8.20$17.00Buy
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
11/4/2025Reiterated Rating$5.20$15.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
11/4/2025Boost Price Target$197.85$220.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
10/27/2025Lower Price Target$14.21$48.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
10/17/2025Reiterated Rating$5.08$12.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
10/14/2025Reiterated Rating$4.26$11.00Buy
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
10/7/2025Boost Price Target$8.30$17.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
9/26/2025Boost Price Target$57.69$73.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
9/26/2025Boost Price Target$8.00$20.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
8/22/2025Lower Price Target$145.70$216.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
8/20/2025Reiterated Rating$3.43$11.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
8/15/2025Boost Price Target$46.10$60.00Buy
Metagenomi, Inc. stock logo
MGX
Metagenomi
8/15/2025Lower Price Target$1.86$11.00Buy
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
8/15/2025Lower Price Target$4.72$15.00Buy
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
8/14/2025Reiterated Rating$6.10$15.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
8/14/2025Reiterated Rating$3.04$13.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
8/12/2025Reiterated Rating$5.53$25.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
8/12/2025Boost Price Target$2.91$10.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
8/11/2025Lower Price Target$10.79$60.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
8/11/2025Lower Price Target$2.86$11.00Buy
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
8/8/2025Lower Price Target$2.64$20.00Buy
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
8/8/2025Lower Price Target$3.79$10.00Buy
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
8/8/2025Reiterated Rating$1.58$12.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
8/7/2025Reiterated Rating$0.67$9.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
8/5/2025Reiterated Rating$134.94$219.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
8/5/2025Reiterated Rating$55.59$82.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
8/1/2025Reiterated Rating$4.50$25.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
7/25/2025Reiterated Rating$150.00$219.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
7/24/2025Lower Price Target$3.21$12.00Buy
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
7/23/2025Reiterated Rating$3.13$25.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
7/3/2025Reiterated Rating$4.31$25.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
6/26/2025Reiterated Rating$46.39$82.00Buy
Passage Bio, Inc. stock logo
PASG
Passage Bio
6/24/2025Reiterated Rating$6.70$120.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
6/18/2025Reiterated Rating$1.82$13.00Buy
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
6/12/2025Reiterated Rating$2.81$12.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
5/29/2025Boost Price Target$2.44$9.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
5/28/2025Lower Price Target$2.33$17.00Buy
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
5/19/2025Lower Price Target$2.77$15.00Buy
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
5/19/2025Lower Price Target$1.29$12.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
5/16/2025Boost Price Target$6.72$46.00Buy
Century Therapeutics, Inc. stock logo
IPSC
Century Therapeutics
5/16/2025Lower Price Target$0.56$6.00Buy
Metagenomi, Inc. stock logo
MGX
Metagenomi
5/15/2025Lower Price Target$1.50$12.00Buy
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
5/13/2025Lower Price Target$2.63$20.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
5/9/2025Reiterated Rating$8.28$68.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
5/9/2025Reiterated Rating$0.44$9.00Buy
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
5/9/2025Lower Price Target$1.76$25.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
5/9/2025Lower Price Target$6.97$45.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
5/9/2025Lower Price Target$3.08$25.00Buy
Oil is settling in yuan now - here's what that means for gold (Ad)

Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every country on Earth to hold U.S. dollars to buy oil. Since then, Saudi Arabia has signed a $7 billion currency swap with China, begun settling oil in digital yuan, and joined China's cross-border payment system, mBridge. With 10-year Treasury yields pushing toward the 4.4% danger line and global dollar demand in retreat, gold is being repriced. There's one asset that still trades at a steep discount to gold's current price - a rare opportunity to leverage the metal's continued rise.tc pixel

Learn how to position ahead of the dollar's continued decline
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
5/7/2025Reiterated Rating$139.47$219.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
5/7/2025Lower Price Target$33.21$82.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
5/6/2025Reiterated Rating$1.25$13.00Buy
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
5/2/2025Reiterated Rating$3.25$12.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
4/9/2025Initiated Coverage$20.51$50.00Buy
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
4/8/2025Lower Price Target$1.79$22.00Buy
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
3/25/2025Reiterated Rating$4.09$25.00Buy
Century Therapeutics, Inc. stock logo
IPSC
Century Therapeutics
3/24/2025Lower Price Target$0.56$7.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
3/24/2025Reiterated Rating$1.80$13.00Buy
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
3/20/2025Boost Price Target$2.00$16.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
3/12/2025Lower Price Target$0.54$9.00Buy
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
3/7/2025Reiterated Rating$5.42$16.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
3/4/2025Lower Price Target$4.14$28.00Buy
Passage Bio, Inc. stock logo
PASG
Passage Bio
3/4/2025Lower Price Target$8.51$120.00Buy
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
3/3/2025Lower Price Target$4.24$30.00Buy
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
3/3/2025Reiterated Rating$2.52$15.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
2/28/2025Lower Price Target$9.49$54.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
2/28/2025Lower Price Target$9.92$68.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
2/26/2025Reiterated Rating$1.62$7.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
2/20/2025Boost Price Target$176.17$218.00Buy
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
2/19/2025Boost Price Target$5.30$16.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2/13/2025Lower Price Target$43.30$84.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
2/11/2025Lower Price Target$5.32$30.00Buy
CARGO Therapeutics, Inc. stock logo
CRGX
CARGO Therapeutics
1/30/2025Downgrade$13.19Neutral